Please login to the form below

Not currently logged in


This page shows the latest corruption news and features for those working in and with pharma, biotech and healthcare.

Millennials and health

Millennials and health

In China corruption and fake drugs emerge as an issue too.

Latest news

More from news
Approximately 10 fully matching, plus 82 partially matching documents found.

Latest Intelligence

  • Risky business for pharma Risky business for pharma

    to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... especially, but not only, in the US”and he added that “[f] or [GSK], like

  • Stress testing for the perfect compliance storm Stress testing for the perfect compliance storm

    Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... industry. The business model of pharmaceutical and life science

  • Tracking comms trends: tackling reputational issues head on Tracking comms trends: tackling reputational issues head on

    Exploitation. Nightmare. Corruption. These are just three of the words that appear on the first page of results when you Google 'pharmaceutical companies' online.

  • Choosing wisely Choosing wisely

    More conservative companies may be put off by allegations of corruption there.

  • The Heart of the Matter 5 - the only way is ethics The Heart of the Matter 5 - the only way is ethics

    corruption. In 2013 alone pharma forked out almost $3.75bn in settlement fees, with the cumulative five-year total extending beyond $10bn. ….

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    Other problems befalling Colombia’ s healthcare system include corruption among the EPS providers – 14 out of 22 EPS-C providers have been sanctioned for collusion and there are allegations of fraud, ... In a move to combat corruption, the EPS are

  • Is MINT the next BRIC?

    For example: governmental promotion of generics in Brazil, heavy pharmaceutical marketing restrictions in Russia, controversial patent legislation in India and the recent clampdown on industry corruption in China.

  • Ageing in China: The Implications for Healthcare

    A hint of this trend is suggested by the ongoing campaign to reduce unnecessary and profit-driven prescriptions, as well as the recent anti-corruption investigations against multinational pharmaceutical companies.

  • The heart of the matter - Part 5

    Rise of the CIA. The battle to curb corruption has seen the introduction of Corporate Integrity Agreements (CIA) in the US, requiring pharmaceutical companies to put in place a comprehensive compliance ... The increased pressure to bolster compliance

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...